Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
About this Journal
Privacy Statement
Open access policy
Cost of publication
Guides for authors
Current
Archives
Editorial Board
Submissions
Archive 2018-2006
Contact
Register
Login
Home
/
Search
Search
Search articles for
Advanced filters
Published After
Year
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
Year
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search
Search Results
Found 217 items.
Redox dependent features of tumors, adipose tissue, neutrophiles and platelets in patients with metastatic colorectal cancer
A.P. Burlaka, S.V. Virko, A.A. Burlaka, K.L. Krupnyk
261-265
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16571
HUMAN MICROBIOTA AND BREAST CANCER
Yu.V. Shvets, O.O. Lykhova, V.F. Chekhun
95-106
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17855
WELCOME ADDRESS
V. Chekhun
186
04.06.2023
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
S.I. Kirkilevsky, P.S. Krakhmalev, N.V. Malyshok, T.V. Zadvornyi, T.V. Borikun, T.M. Yalovenko
167-171
31.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.14822
EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA
Wani Zahoor, Arshad A. Pandith, Syed Nisar, Iqbal Qasim, Menka Surana, Farooq A. Ganie, Usma Manzoor, Sajad H. Arif, Shayaq Ul Abeer Rasool, Adil Lateef, Parveen Shah, Rashid A. Bhat
203-210
11.10.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.203
MATERIALS OF NOBEL SYMPOSIUM 175: PRECISION MEDICINE TRANSFORMS HEALTHCARE: A NEW TRAJECTORY FOR RESEARCH AND INNOVATION SEPTEMBER 20—22, 2023, STOCKHOLM, SWEDEN
L. Kovalevska, E. Kashuba
531-534
12.12.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.04.531
PD-1 AND TIM-3 BLOCKING CANNOT ENHANCE APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY PERIPHERAL BLOOD CD8+ T CELLS
S. Jafarkhani, H. Hossein-Nataj, M. Eslami-Jouybari, M. Ghoreishi, H. Asgarian-Omran
287-294
09.03.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18975
EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW
R. SARATHI, S. SARUMATHY, V.M. DURAI MAVALAVAN
185-191
19.12.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.03.185
THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA
О. Kravets, O. Burtyn, T. Borikun, O. Rossylna
187-194
11.10.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.187
ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS
E.A. Domina, O.L. Kopylenko
186-189
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18530
Quinazoline compounds for antitumor treatment
G.I. Solyanik
3-6
08.06.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12414
EXPRESSION OF GENES INVOLVED IN P53 PATHWAY REGULATION IN NEUROBLASTOMA: A SHORT REVIEW
M. Inomistova, H. Klymniuk, N. Khranovska , S. Pavlyk, E. Shaida, O. Gorbach, O. Skachkova, D. Shymon
266–271
07.03.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18960
ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS
O. Pridko, T. Borikun, O. Rossylna, A.V. Rusyn
180-186
11.10.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.180
Comparative evaluation of purine dysmetabolism in gastric and pulmonary adenocarcinomas
Y.V. Dumanskiy, O.Y. Stoliarova, О.V. Syniachenko, R.F. Aliev, М.V. Iermolaeva, О.P. Sokrut
220-223
31.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-3.15068
IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY
M. GOLOVENKO, I. VALIVODZ, A. REDER, V. LARIONOV
51-59
11.07.2025
DOI:
https://doi.org/10.15407/exp-oncology.2025.01.051
PROGNOSTIC VALUE OF THE DENSITY OF TUMOR-INFILTRATING LYMPHOCYTES AND ITS ASSOCIATION WITH CLINICAL-MORPHOLOGICAL FEATURES OF COLON ADENOCARCINOMAS
B. SHKURUPII, L. ZAKHARTSEVA
45-52
31.05.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.01.045
IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY
Yu.V. Dumanskyi, S.I. Kirkilevskyi, O.M. Sulaeva, V.O. Polyasnyi, A.O. Mashukov, L.A. Kovalevska, R.R. Yarema, M.A. Ogorchak
324–326
07.03.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.18903
PHARMACOGENETIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY
L. Fishchuk, Z. Rossokha, N. Levkovych, O. Sheiko, O. Ievseienkova, L. Brisevac, O. Popova, V. Vershyhora, N. Gorovenko
408-420
05.03.2026
DOI:
https://doi.org/10.15407/exp-oncology.2025.04.408
GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS
L. Fishchuk, O. Skavinska, O. Ievseienkova, Z. Rossokha, L. Sheiko
399-408
12.12.2023
DOI:
https://doi.org/10.15407/exp-oncology.2023.04.399
Peculiarities of epithelial-mesenchymal transition in endometrial carcinomas
I. Nesina
282-289
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.16982
SEVERE DISEASE PROGRESSION OF POSTMOLAR GESTATIONAL NEOPLASM IN A VIETNAMESE YOUNG FEMALE PATIENT AFTER TREATMENT REFUSAL: INSIGHTS FROM A CASE REPORT AND LITERATURE REVIEW
THANH NHAN VO, PHUC NHON NGUYEN
154-164
09.10.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.02.154
PRIMARY OVARIAN SYNOVIAL SARCOMA — A CASE REPORT
A. Yordanov, K. Janeva, S. Mateva, Y. Kornovski, S. Kostov, S. Slavchev, Y. Ivanova, M. Nikolova
334-336
09.03.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19072
Collision breast cancer and chronic lymphocytic leukemia/small lymphocytic lymphoma in a single lymph node (clinical case)
L. Zakhartseva, M. Yanovytska
274-276
26.05.2023
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16486
THE UBIQUITIN-PROTEASOME SYSTEM IN CANCER: MECHANISMS, TARGETS AND THERAPEUTIC POTENTIAL
D. Nishchenko, S. Antonenko, D. Gurianov, M. Tesliuk, G. Telegeev
395-407
05.03.2026
DOI:
https://doi.org/10.15407/exp-oncology.2025.04.395
Digital Pathology as an Innovative Tool for Improving Cancer Diagnosis and Treatment
T. ZADVORNYI
289-294
12.12.2024
DOI:
https://doi.org/10.15407/exp-oncology.2024.04.289
176 - 200 of 217 items
<<
<
3
4
5
6
7
8
9
>
>>
Language
Українська
English
Make a Submission
Make a Submission